Literature DB >> 19107148

Treacher Collins syndrome: etiology, pathogenesis and prevention.

Paul A Trainor1, Jill Dixon, Michael J Dixon.   

Abstract

Treacher Collins syndrome (TCS) is a rare congenital disorder of craniofacial development that arises as the result of mutations in the TCOF1 gene, which encodes a nucleolar phosphoprotein known as Treacle. Individuals diagnosed with TCS frequently undergo multiple reconstructive surgeries, which are rarely fully corrective. Identifying potential avenues for rescue and/or repair of TCS depends on a profound appreciation of the etiology and pathogenesis of the syndrome. Recent research using animal models has not only determined the cellular basis of TCS but also, more importantly, unveiled a successful avenue for therapeutic intervention and prevention of the craniofacial anomalies observed in TCS.

Entities:  

Mesh:

Year:  2008        PMID: 19107148      PMCID: PMC2986179          DOI: 10.1038/ejhg.2008.221

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  42 in total

1.  MANDIBULOFACIAL DYSOSTOSIS, A FAMILIAL STUDY OF FIVE GENERATIONS.

Authors:  S ROVIN; S F DACHI; D B BORENSTEIN; W B COTTER
Journal:  J Pediatr       Date:  1964-08       Impact factor: 4.406

2.  Mandibulofacial dysostosis.

Authors:  J J STOVIN; J A LYON; R L CLEMMENS
Journal:  Radiology       Date:  1960-02       Impact factor: 11.105

3.  Mutations in the Treacher Collins syndrome gene lead to mislocalization of the nucleolar protein treacle.

Authors:  K L Marsh; J Dixon; M J Dixon
Journal:  Hum Mol Genet       Date:  1998-10       Impact factor: 6.150

4.  Characterization of the nucleolar gene product, treacle, in Treacher Collins syndrome.

Authors:  C Isaac; K L Marsh; W A Paznekas; J Dixon; M J Dixon; E W Jabs; U T Meier
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

5.  Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.

Authors:  J Dixon; C Brakebusch; R Fässler; M J Dixon
Journal:  Hum Mol Genet       Date:  2000-06-12       Impact factor: 6.150

6.  TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins Syndrome throughout its coding region.

Authors:  C A Wise; L C Chiang; W A Paznekas; M Sharma; M M Musy; J A Ashley; M Lovett; E W Jabs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene.

Authors:  J Dixon; S J Edwards; I Anderson; A Brass; P J Scambler; M J Dixon
Journal:  Genome Res       Date:  1997-03       Impact factor: 9.043

Review 8.  Living with p53, dying of p53.

Authors:  Yael Aylon; Moshe Oren
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

9.  Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.

Authors:  Natalie C Jones; Megan L Lynn; Karin Gaudenz; Daisuke Sakai; Kazushi Aoto; Jean-Phillipe Rey; Earl F Glynn; Lacey Ellington; Chunying Du; Jill Dixon; Michael J Dixon; Paul A Trainor
Journal:  Nat Med       Date:  2008-02-03       Impact factor: 53.440

10.  Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.

Authors:  Jill Dixon; Natalie C Jones; Lisa L Sandell; Sachintha M Jayasinghe; Jennifer Crane; Jean-Philippe Rey; Michael J Dixon; Paul A Trainor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

View more
  50 in total

Review 1.  Treacher Collins syndrome: clinical implications for the paediatrician--a new mutation in a severely affected newborn and comparison with three further patients with the same mutation, and review of the literature.

Authors:  Jan-Ulrich Schlump; Anja Stein; Ute Hehr; Tanja Karen; Claudia Möller-Hartmann; Nursel H Elcioglu; Nadja Bogdanova; Hartmut Fritz Woike; Dietmar R Lohmann; Ursula Felderhoff-Mueser; Annette Linz; Dagmar Wieczorek
Journal:  Eur J Pediatr       Date:  2012-06-23       Impact factor: 3.183

2.  Treacher Collins syndrome with microcornea and retinal detachment.

Authors:  Abijith Holla; Sarita R J Gonsalves; Geover Joslen Lobo
Journal:  BMJ Case Rep       Date:  2013-12-11

Review 3.  Syndromes of the first and second branchial arches, part 1: embryology and characteristic defects.

Authors:  J M Johnson; G Moonis; G E Green; R Carmody; H N Burbank
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

4.  Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation.

Authors:  Michael Olaopa; Hong-ming Zhou; Paige Snider; Jian Wang; Robert J Schwartz; Anne M Moon; Simon J Conway
Journal:  Dev Biol       Date:  2011-05-12       Impact factor: 3.582

5.  Deletion of Drosophila Nopp140 induces subcellular ribosomopathies.

Authors:  Fang He; Allison James; Himanshu Raje; Helya Ghaffari; Patrick DiMario
Journal:  Chromosoma       Date:  2014-11-11       Impact factor: 4.316

Review 6.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

7.  Use of the GlideScope® for enhanced airway challenges in Treacher Collins syndrome.

Authors:  Vanita Ahuja; Tenzin Nyima; Parul Verma; Parmanand Gupta
Journal:  Indian J Anaesth       Date:  2020-02-04

Review 8.  Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.

Authors:  Daisuke Sakai; Paul A Trainor
Journal:  Dev Growth Differ       Date:  2016-08-02       Impact factor: 2.053

Review 9.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12

Review 10.  Modeling craniofacial and skeletal congenital birth defects to advance therapies.

Authors:  Cynthia L Neben; Ryan R Roberts; Katrina M Dipple; Amy E Merrill; Ophir D Klein
Journal:  Hum Mol Genet       Date:  2016-06-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.